Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07467317) titled 'BV-CHP Real-life and Biological Evidences in Patients With sALCL' on Feb. 26.
Study Type: Observational
Primary Sponsor: Fondazione Italiana Linfomi - ETS
Condition:
Anaplastic Large Cell Lymphoma
Recruitment Status: Not recruiting
Date of First Enrollment: May 2026
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/study/NCT07467317
Published by HT Digital Content Services with permission from Health Daily Digest....